Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
206.7 EUR | -0.48% | -0.86% | -13.78% |
04-23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
04-22 | Sartorius Stedim: in the red with brokerage comments | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.78% | 21.78B | |
-4.65% | 182B | |
+0.56% | 110B | |
-3.64% | 67.92B | |
+4.10% | 50.96B | |
+9.75% | 44.7B | |
+2.70% | 40.66B | |
+19.63% | 27.6B | |
+5.37% | 26.63B | |
-0.02% | 24.98B |
- Stock Market
- Equities
- DIM Stock
- News Sartorius Stedim Biotech
- Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft, H1 2023 Earnings Call, Jul 21, 2023